IS BUSH THE BEST FRIEND OF EMBRYO RESEARCH?
Writing in the libertarian magazine Reason, Ronald Bailey asks whether Federal restrictions have helped, rather than hindered, embryonic stem cell research. Because the Bush Administration set limits on Federal funding, without actually banning the research, scientists have gone to the states and to philanthropists to plead for funds. He likens it to research into assisted reproduction which has had very little Federal regulation and oversight. Promising research halted only when the Federal government stepped in to regulate it.
Although scientists are convinced that government funding is essential to kickstart basic research, business spending on R&D is what really pushes a field ahead. “Economic growth [is] associated almost entirely with private sector research funding,” Bailey argues, citing an OECD 2001 report. “As private donors and states continue to shovel tens of millions at stem cell researchers,” he concludes, “it may just be that President Bush did embryonic stem cell research a huge favour when he imposed restrictions on federal funding of it.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...